Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
Register for free to join our community of investors and share your ideas. You will also get access to streaming quotes, interactive charts, trades, portfolio, live options flow and more tools.
NGW_General Corporate Updated_Financing
Next Green Wave Holdings Inc. Announces CDN$6.3 Million in Financings
VANCOUVER, B.C. — November 22, 2019 — Next Green Wave Holdings Inc. (CSE: NGW) (OTCQX: NXGWF) (“Next Green Wave”, “NGW” or the “Company”), today announced:
Next Green Wave has completed an asset-backed financing with Landrace Financial (the “Lender”) for a loan (the “Loan”) in the amount of CDN$5,300,000.
“A financing collateralizing US cannabis assets is extremely rare; the fact that we were able to accomplish an asset-backed financing at our relatively early stage of existence is very encouraging and speaks to the Lender’s high confidence in the potential of our Company. It is our expectation that we will achieve both positive cash flow and profitability in the first half of 2020. NGW’s world class indoor cultivation facility has been in a perpetual harvest (with a harvest approximately every second week) for several weeks now and the Loan will allow us to accelerate our distribution, branding and marketing initiatives across the State of California. We now have almost $1 million of premium inventory that we are readying for sale – our goal is to turn all our flower and trim into premium cannabis products yielding a much higher return than selling in bulk.” said Chief Executive Officer Michael Jennings.
The Loan is for a two-year term. Interest on the Loan will be paid monthly in cash: (i) at a rate of 10.5% per annum; plus (ii) the greater of (a) 2.5% and (b) LIBOR rate; plus any default rate. The outstanding principal of the Loan and all outstanding interest thereon will be payable in full on the maturity date. In addition, the Lender will receive a total of 6,500,000 common share purchase warrants having a term of 36 months from the date the Loan is disbursed to NGW (the “Advance Date”) exercisable into common shares of NGW (the “Share”) at a price of CDN$0.20 per share.
Furthermore, the Company has agreed to a non-brokered private placement of 6,666,666 Shares at a price of CDN$0.15 per Share for gross proceeds of CDN$1,000,000 (the “Financing”). The parties to the Financing are all at arm’s-length and there are no finder’s fees payable. Closing is subject to a number of conditions, including regulatory approval. All securities will be held for a period of 4-months from closing of the Financing.
The proceeds from the Financing plus CDN$500,000 will be used to reduce outstanding unsecured convertible notes from CDN$3,000,000 to CDN$1,500,000. Concurrent with the closing of the Financing, the Company will amend the terms of the remaining CDN$1,500,000 of convertible debentures from a conversion rate of CDN$0.388 per share to a price of CDN$0.15. In addition, the Company will reprice the 7,732,357 share purchase warrants previously issued with the notes (CDN$0.48) to a price of CDN$0.20 per warrant (for a period of 24 months from the date of issue), collectively (the “Re-pricing”). The Re-pricing is also subject to a number of conditions, including regulatory approval.
Full terms of the Notes were referenced in the Company’s news release dated May 30, 2019.
In addition, 1,000,000 warrants issued on Sep 12, 2019, have been re-priced from $0.35 to $0.25, all other terms remain the same.
The Company has granted 3,530,000 stock options under its stock option plan (the “Grant”) exercisable at a price of CDN$0.15 per Share to a director, employees and HR consultants of the Company. As per the Company’s stock option plan, the options granted are exercisable until November 19, 2024. The Grant has a vesting period of 25%, every 6 months, for a period of 24 months.
The Company also announces that pursuant to the SDC Purchase Agreement (described in the Company’s News Release of March 12, 2019), effective Nov 19, 2019 it has released the 16,167,092 SDC shares from escrow. The Release is still subject trading restrictions under the Securities Act of 1933, as amended, and applicable State securities laws.
About Next Green Wave
NGW is a fully integrated premium cannabis producer with 8 legacy brands and over 45 products marketed through its WEARESDC brand house. Based in Coalinga, California the company owns and operates a 35,000 sq ft. state-of-the-art indoor cultivation facility and is currently expanding extraction and other operations on its cannabis zoned campus. NGW has a seed library of over 120 cannabis strains which include multiple award-winning genetics and cultivars and is developing its nursery cloning operations with bio-tech leader Intrexon. To find out more visit us at www.nextgreenwave.com or follow us on Twitter, Instagram, or LinkedIn.
On behalf of the Board,
Michael Jennings, CEO
Next Green Wave Holdings Inc.
For more information regarding Next Green Wave, contact:
Caroline Klukowski
VP Corp. Development
Tel: +1.604.609.6167
IR@nextgreenwave.com
Facebook
Twitter
Instagram
Next Green Wave 300-1055 West Hastings St. Vancouver British Columbia V6E 2E9
You received this email because you are subscribed to NGW from Next Green Wave
Update your email preferences to choose the types of emails you receive.
Unsubscribe from all future emails
This press release does not constitute an offer to sell or the solicitation of an offer to buy any securities.
Next Green Wave Forward Looking Statements
This press release contains forward-looking statements within the meaning of applicable securities laws. All statements that are not historical facts, including without limitation, statements regarding future estimates, plans, programs, forecasts, projections, objectives, assumptions, expectations or beliefs of future performance, are “forward-looking statements.” Forward-looking statements can be identified by the use of words such as “plans”, “expects” or “does not expect”, “is expected”, “estimates”, “intends”, “anticipates” or “does not anticipate”, or “believes”, or variations of such words and phrases or statements that certain actions, events or results “may”, “could”, “would”, “might” or “will” be taken, occur or be achieved. Such forward-looking statements involve known and unknown risks, uncertainties and other factors that may cause actual results, events or developments to be materially different from any future results, events or developments expressed or implied by such forward looking statements. Such risks and uncertainties include, among others, the risk factors included in the preliminary prospectus, including without limitation dependence on obtaining and maintaining regulatory approvals, including acquiring and renewing state, local or other licenses and any inability to obtain all necessary governmental approvals licenses and permits to complete construction of its proposed facilities in a timely manner; engaging in activities which currently are illegal under US federal law and the uncertainty of existing protection from U.S. federal or other prosecution; regulatory or political change such as changes in applicable laws and regulations, including U.S. state-law legalization, particularly in California, due to inconsistent public opinion, perception of the medical-use and adult-use marijuana industry, bureaucratic delays or inefficiencies or any other reasons; any other factors or developments which may hinder market growth; NGW’s limited operating history and lack of historical profits; reliance on management; NGW’s requirements for additional financing, and the effect of capital market conditions and other factors on capital availability; competition, including from more established or better financed competitors; and the need to secure and maintain corporate alliances and partnerships, including with customers and suppliers. Readers are encouraged to the review the section titled “Risk Factors” in NGW’s preliminary prospectus. These factors should be considered carefully, and readers are cautioned not to place undue reliance on such forward-looking statements. Although NGW has attempted to identify important risk factors that could cause actual actions, events or results to differ materially from those described in forward-looking statements, there may be other risk factors that cause actions, events or results to differ from those anticipated, estimated or intended.
There can be no assurance that forward-looking statements will prove to be accurate, as actual results and future events could differ materially from those anticipated in forward-looking statements. NGW no obligation to update any forward-looking statement, even if new information becomes available as a result of future events, new information or for any other reason except as required by law.
Chuck,
Police came...…...sell
Chuck,
Please stay for the party and leave before the police come.
HI Guys,
Below is why the weed sector is trading up today.
Would be great to see this come into being.!!
All Content and Data provided by Third-Parties — Terms of Use
Cannabis stocks snap six-day losing streak on hopes for bill that would end federal ban
MARKETWATCH 1:18 PM ET 11/19/2019
Symbol Last Price Change
ACB 2.33down +0.05 (+2.19%)
CGC 15.01down +0.79 (+5.56%)
TLRY 20.0562down +0.1462 (+0.73%)
APHA 4.185down +0.365 (+9.55%)
ALEAF 0.50795down +0.02085 (+4.28%)
HEXO 1.8up +0.21 (+13.21%)
OGI 2.3099up +0.2499 (+12.13%)
MMNFF 0.614up -0.1439 (-18.99%)
HRVSF 2.6down -0.05 (-1.89%)
MJ 16.5up +0.43 (+2.68%)
QUOTES AS OF 01:19:04 PM ET 11/19/2019
Aurora Cannabis (ACB) says 94% of its convertible bondholders are opting for a highly dilutive deal that is 'terrible precedent,' according to one analyst
Cannabis stocks rose Tuesday and were on track to end a six-day losing streak (http://www.marketwatch.com/story/ cannabis-stocks-are-a-sea-of-red-again-as-selloff-stretches-to-sixth-straight-day-2019-11-18), buoyed by news that a congressional committee is advancing a bill that would lift the federal ban on cannabis and overturn past convictions.
The House Judiciary Committee is planning a markup on Wednesday on the Marijuana Opportunity Reinvestment and Expungement Act (More Act), according to Committee Chairman Jerrold Nadler, a New York Democrat.
Nadler, along with Rep. Barbara Lee, a California Democrat, Rep. Earl Blumenauer, a Democrat from Oregon and additional members of Congress, are holding a press conference on Tuesday to highlight the legislation.
"Our marijuana laws disproportionately harm individuals and communities of color, leading to convictions that damage job prospects, access to housing, and the ability to vote." Nadler said in a statement. "Recognizing this, many states have legalized marijuana. It's now time for us to remove the criminal prohibitions against marijuana at the federal level."
The news "is a positive for the industry and investors are likely baking some of that into stocks," said Craig Behnke, equity analyst at Marijuana Business Daily (MBD).
Read now: All the excuses cannabis companies are making for an ugly crop of earnings (http://www.marketwatch.com/ story/all-the-excuses-cannabis-companies-are-making-for-an-ugly-crop-of-earnings-2019-11-17)
It's far from certain that the bill would be taken up by the Senate, however. The Senate has for now failed to take up a bill passed by the House (http://www.marketwatch.com/story/house-expected-to-pass-cannabis-banking-bill-but-getting- senates-ok-still-looks-tricky-2019-09-24)that would protect banks that serve the cannabis industry in those states that have legalized. Sen. Mitch McConnell, the majority leader of the Republican-controlled Senate, is a longtime opponent of cannabis legalization, although he did meet with cannabis executives on a recent trip to California (http:// www.marketwatch.com/story/mitch-mcconnell-travels-to-california-where-pot-execs-pitch-need-for-cannabis-banking-reform- 2019-10-09) and heard pitches for banking reform.
Read also: Cannabis stocks mostly lower as euphoria over banking bill fades in face of tricky U.S. Senate path (http:/ /www.marketwatch.com/story/cannabis-stocks-mixed-as-euphoria-over-banking-bill-fades-in-face-of-tricky-senate-2019-09- 26)
Most of the stocks that have been battered in recent sessions were higher Tuesday, as investors searched for bargains after months of selling.
"It's a bit of a paradox, but the worse things get for the sector, in terms of stock price, and how badly companies are missing the current quarter's estimates and reducing forward guidance, the better," said MBD's Behnke. "It has to happen to wash out all the excesses that were built into expectations that were completely unrealistic."
The recent wave of announcements of cost cuts, asset sales, sale-and-leaseback arrangements involving real estate and canceled deals are necessary to get capacity in line with consumer demand and allow the industry to be anchored in realistic growth expectations, he said. There's more bad news to come, there'll be more downsizing and reining in expansion plans, "but all of that has to happen."
Behnke is expecting the next three to nine months to bring the first bankruptcies in the new sector as companies run out of cash and find capital markets access prohibitively expensive or highly dilutive. Aurora Cannabis's(ACB) (ACB.T) decision to reprice its convertible debt on terms that were highly dilutive to its existing equity holders "was absolutely stunning," he said.
Aurora said last week it was offering holders of C$230 million ($174 million) of 5% convertible notes that mature in March of 2020 the chance to voluntarily convert them to stock at a conversion ratio equal to a 6% discount over the stock's five-day volume weighted average trading price on the Canadian and U.S. exchanges. The company said early Tuesday that 94% of bondholders had taken up the offer.
See now:Canopy Growth CEO defends ugly quarter as one-time event (http://www.marketwatch.com/story/canopy-growth-ceo- defends-ugly-quarter-as-one-time-event-2019-11-14)
"It's a terrible precedent to set" and "an incredibly desperate set of measures," according to Behnke, echoing analyst views from last week. The move has diluted the shares of anyone who bought them at the market peak earlier this year, he said. "Investors will likely be very reluctant to invest in cannabis in the form of equity" if they see that debtholders, who are already above them in the capital structure, are getting preferential treatment, said the analyst.
Aurora announced the news along with disappointing earnings and the announcement it is halting construction on some facilities to conserve cash, giving it its worst-trading day Friday in more than five years (http://www.marketwatch.com/ story/aurora-cannabis-stock-plunges-to-two-year-low-as-analysts-lose-faith-2019-11-15). The stock was up 3.5% Tuesday, but remains down 36% in the month to date.
Elsewhere in the sector, market leader Canopy Growth Corp.(CGC) (WEED.T) was up 4%, Tilray(TLRY) was up 0.9%, Aphria Inc.(APHA) (APHA.T) was up 84% and Cronos (CRON.T)(CRON.T) was up 2%.
Aleafia Health (ALEAF) was up 4%, Hexo(HEXO) (HEXO.T) was up 10% and Organigram(OGI) was up 11%.
But retailer MedMen(MMNFF) fell another 18%, after it announced job cuts and asset sales last week. GW Pharma (GWPH) was down 0.1%, Harvest health & Recreation(HRVSF) was down 1%.
The ETFMG Alternative Harvest ETF(MJ) was up 2% with 25 of its 36 constituents trading higher. The Horizons Marijuana Life Sciences ETF was up 2.6% with 33 of its 54 member stocks higher.
The S&P 500 was flat and the Dow Jones Industrial Average was down 0.3%.
Cannabis Watch: Click here for all of MarketWatch's coverage of cannabis companies (http://www.marketwatch.com/ storyno-meta-for-guid)
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
11-19-191318ET
Copyright (c) 2019 Dow Jones & Company, Inc.
Hi Guys,
We can all say "Mount Vesuvius" when NGW makes its move higher with month end business update at the end of the month.
Hi Guys,
So as the stock market weed companies fail to perform we see that they also are ( "throwing the "BABY" (NGW) out with the bath water" ).
We all sit and wait for NGW up coming earnings report to set things straight about NGW.
We are not over valued at these levels from a projected price to sales market valuation.
Therefore I am calling a low here. Yes I did say it here we are at a all time low in our share price at these levels.
You all can call me a hero or a bum in the next few months.
GLTA
Sorry Chuck29 but that is the reality.
Hi Buhlz I,
Just trying to keep things real. Let's not get too ahead of ourselves here.
We should know some more details since the SEC filing for the second quarter is due 45 days after the quarter end.
That means NGW needs to issue their second quarter report on or before November 15, 2019.
We should know a lot more about the company from this required information.
GLTA
Cresus,
I am just being realistic...……...NGW has 156 MM shares outstanding
If it trades at $1.00 per share its market cap is $156 MM
With sales at $45 MM per year ( my forecast for 2020 ) then at the share price of $1.00 per share NGW would be trading at 3.4 times sales.
For now the market place is not giving the Weed companies this type of valuation.
It is more like approx. 1- 2 times sales depending upon market position and debt.
So there you have it in a nutshell...
Very early in the game...…..IMO we will see $1.00 per share and much more. But this is a much longer term play to reach these levels.
In the next couple of years as they build out their 50,000 and then their 250,000 sq ft. facilities as zone for on their existing site we should see much, much higher share prices. My thinking is to see the share price rising to the high single digits.
We all just have to be realistic here as to where NGW is at in their business growth.
Forecast for sales year 2021
Full production Site A
Full production Site C extraction
Sales consists of Flower, seedlings, extraction production, lotions and tintures.
My forecast $45 MM per year end 2021
We should easily see the stock trading over $ .50 per share.
And any other business development, and or Weed market place expansion, or government state or federal easing of rules should drive this much higher.
GLTA
Clonemaster,
Very well stated. My thoughts exactly!!
Yes,
That is why I added to my long position today!!
GLTA
Read a recent article about the current valuations of U.S. weed stocks.
Summary as follows...…..large companies valuation 2.9 x sales
med. companies valuation 1.4 x sales
small companies valuation .9 x sales
So NGW as small company we are very under valued. We should be trading at or near $.25
This would give us a valuation close to the average of .9 x sales for small companies.
Food for thought...……….
See you all at $.25 on the rise waiting for 4th quarter sales numbers.
Hi Guys,
Finally we are getting some upgrade in the "Weed" sector!!!
Data provided by Third-Parties — Terms of Use
--Analyst Actions: Cantor Fitzgerald Starts Aurora Cannabis at Neutral With C$5.10 Price Target
MT NEWSWIRES 11:26 AM ET 11/5/2019
11:26 AM EST, 11/05/2019 (MT Newswires) --
Price: 3.77, Change: +0.17, Percent Change: +4.58
MT Newswires does not provide investment advice. Unauthorized reproduction is strictly prohibited.
©http://www.mtnewswires.com Copyright © 2019 MT Newswires. All rights reserved.
And nice to see some small movement with NGW but ok % wise move
GLTA
Hi Guys,
Just read the below, and sit back and enjoy our ride!!!
Looks like high quality weed is the market place to be.
I am not touting the other vendors mentioned in this article.
Only that high quality is the market place to bring us a winner.
All Content and Data provided by Third-Parties — Terms of Use
Officials Promote the Legal Cannabis Industry as Health Concerns AbateFinancialBuzz.com News Commentary
PR NEWSWIRE 9:00 AM ET 10/30/2019
Symbol Last Price Change
TLRY 22.52down +0.37 (+1.67%)
ACB 3.6357up +0.0357 (+0.99%)
QUOTES AS OF 10:15:43 AM ET 10/30/2019
NEW YORK , Oct. 30, 2019 /PRNewswire/ -- While the global cannabis industry has grown at a remarkable pace over the past several years, its growth has been hindered by burdensome regulatory challenges. As numerous countries have moved to either decriminalize cannabis for adult-use in the past decade, others have decided to legalize cannabis solely for medicinal purposes. Notably, countries such as the U.S. and Canada are thriving in the recreational market because of their large legal channels. However, recreational markets have come under intense scrutiny due to the influx of tainted products from the black market. In recent months, hundreds of medical cases have emerged related to vaping and the Centers for Disease Control and Prevention noted that THC vape products have played a major role in the outbreak. The CDC mentioned that vape products purchased from illicit vendors should be disposed of immediately and advised consumers to obtain their products from authorized retailers. New York health officials have confirmed that synthetic vitamin E is the main threat in tainted vape carts. Moreover, the U.S. Food and Drug Administration found traces of formaldehyde and pesticides in the carts as well. AS such, the data compiled by health officials has deterred many consumers from the market, including the legal industry. Research firm New Frontier discovered that nationwide vape sales even fell by 15% in the first week of September and saw no rebound through September 18th. Specifically, states such as New Mexico, Massachusetts, and Nevada witnessed their sales decline by a third, while California fell by 6%. In response to the epidemic, many industry experts have told consumers to purchase cannabis products from legal vendors, who explicitly mention the additives as well as the growing procedure of the product. And in light of recent events, consumers and federal officials alike are beginning to demand for more stringent research and better-regulated products. According to data compiled by Verified Market Research, the global marijuana market was valued at USD 42.20 Billion in 2016. Furthermore, by 2025, the market is expected to reach USD 466.81 Billion while registering a CAGR of 35.3% from 2018 to 2025. Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT), Tilray, Inc.(TLRY) , Aurora Cannabis Inc.(ACB) , Harvest Health & Recreation, Inc. (OTC: HRVSF) (CSE: HARV), Planet 13 Holdings Inc. (OTC: PLNHF) (CSE: PLTH)
Despite legalization efforts in certain regions, many consumers still tend to purchase their products from illegal vendors. In particular, one year after Canada fully legalized cannabis, 60% of Canadians still obtain their products from black market dealers or sources that are not entirely legal. However, the percentage has steadily fallen since Canada legalized cannabis back in October 2018. Currently, consumers purchase their products from the black market because it is typically much cheaper than obtaining goods from legal vendors. According to a study by Statistics Canada, legal cannabis now costs 65% more than black market products, increasing from 50% in the fourth quarter of 2018. And while legal cannabis may be expensive to most consumers, a study by Brightfield Group discovered that 43% of the respondents were willing to pay more for premium, while just 34% were reluctant to pay more for certified organic products. On the other hand, occasional users were more willing to pay for healthier methods of delivery. Consequently, certain consumers decided to turn towards "craft cannabis." Cultivating craft cannabis is the meticulous process of growing high quality and organic flowers, which can appeal to both spectrums of user demands. Specifically, craft cultivators avoid using any artificial products, such as pesticides and growth stimulants during the growing process. The use of additives can heavily weaken the cannabinoid content within strains and also create an inorganic product. In order to maintain a healthy and potent strain, craft cultivators tend to each and every individual plant to ensure it grows properly. "When it comes to retail, consumers will always pay more for premium-quality products. In the cannabis industry, that means top-shelf genetics cultivated in small batches will fetch higher prices," said Anne Forkutza, former Vice President of Strategic Partnerships and Brand Officer at Cova Software.
Pasha Brands Ltd. (OTC: CRFTF) (CSE: CRFT) is also listed on the Canadian Securities Exchange under the ticker (CSE: CRFT). Yesterday, the Company announced that, "Between 2014 and 2018 global sales of legal cannabis more than tripled from $3.4 billion to $10.9 billion, according to the State of the Legal Cannabis Markets report from Arcview Market Research. BDS Analytics calls for a near-quadrupling from 2018 levels to $40.6 billion by 2024 at an annual growth rate of 21.9%. This has led many people to wonder, why the recent market downturn in the cannabis sector?
'Legal cannabis, particularly in Canada, has been struggling under the weight of burdensome regulations, poor supply-chain management, and quality issues,' said Jamie Shaw, Chief Communications and Culture Officer for Pasha. 'Coupled with that, companies in the sector were slow to deliver the results expected and were generally seen as overvalued. Share prices were determined at a time when there were relatively few licences that seemed to have a stranglehold on the regulated marketplace.'
While these challenges are most pronounced in today's market, for Pasha it has been an affirmation of its business plan. 'We never bought into the big-box mentality that's causing many of these problems," Shaw said. "Pasha has focused on small batch, craft producers, and has been meeting its goals at a quick pace, with the first micro-cultivation harvest expected in December.'
Pasha has been on-boarding brands and people that made legalization possible, including Baked Edibles, Earth Dragon Organics, and Beard Brothers Collective, and has acquired a Health Canada licensed facility on Vancouver Island. Pasha expects to be the first licensed, nation-wide, all-craft company to be operational by end of Q4 2019/early Q1 2020.
Of the first 5 micro-licences issued by Health Canada, Pasha has signed supply agreements with all of them. Pasha also has signed supply agreements with 60 more applicants currently in the CTLS queue with Health Canada, and another 40 navigating the licensing process with Pasha subsidiary, BC Craft Supply Co. Ltd. With 100 micro-cultivators each permitted to produce up to 500kg per year, Pasha could have the ability to bring up to 50,000kg per year of high-quality craft cannabis to Canadian consumers.
'The legal market has yet to see products with the same care and attention to detail that went into the highest quality, illicit products," said Patrick Brauckmann, Executive Chair of Pasha Brands. "Pasha is committed to bringing products to the marketplace that put the consumer first.'
Partnered with powerful distributors like Great North and developing innovative industry solutions like Craft Labs, Pasha looks to disrupt how people think of legal cannabis.
About Pasha Brands: Based in Vancouver, British Columbia, Pasha is a vertically integrated, prohibition-era brand house firmly rooted in BC's craft cannabis industry, which boasts an international reputation. With proven capabilities in cannabis cultivation, genetic research and development, product processing, and retail, Pasha is uniquely positioned in the new legal cannabis market through its network of hundreds of craft cannabis suppliers under the Pasha umbrella. Pasha subsidiary, Medcann Health Products Ltd., is a Health Canada licensed cultivator and processor with a licence to sell medical cannabis products in Canada. Pasha and BC Craft are also developing a craft cannabis campus, which is dedicated to bringing craft quality into the newly legal cannabis market in Canada. BC Craft is driven to assist craft growers in obtaining security clearance and licensing to grow as micro-cultivators, specializing in education and compliance to bring growers into the regulated cannabis supply market. Pasha's common shares trade on the CSE under the symbol "CRFT" and on the FSE under the symbol "ZZD". For more information, please visit www.pashabrands.com."
For our latest "Buzz on the Street" Show featuring Pasha Brands Ltd. recent corporate news, please head over to: https://www.youtube.com/watch?v=FlEwtMmB7fA
Tilray, Inc. (TLRY) is a global pioneer in the research, cultivation, production and distribution of cannabis and cannabinoids currently serving tens of thousands of patients and consumers in 13 countries spanning five continents. Tilray, Inc.(TLRY) recently announced that it had entered into a definitive agreement pursuant to which Tilray(TLRY), through a wholly-owned subsidiary of High Park Holdings Ltd., will acquire all of the issued and outstanding securities of 420 Investments Ltd., an adult-use cannabis retail operator headquartered in Calgary, Alberta. FOUR20 provides adult-use cannabis consumers with a premium retail experience focused on high quality product selection, education and community. FOUR20 currently operates six licensed retail locations and has 16 additional high-traffic locations secured in desirable locations in Alberta, including Canmore, Calgary and Edmonton. Tilray(TLRY) and High Park will leverage FOUR20's retail expertise and brand and market knowledge to expand into other Canadian provincial markets where Licensed Producer retail ownership will be permitted in the future. "FOUR20 offers a premium retail experience for the mainstream cannabis consumer and builds on our broader retail strategy, which includes several minority investments in other leading cannabis retailers," says Tilray(TLRY) Chief Corporate Development Officer Andrew Pucher. "With FOUR20, we will elevate the retail experience for consumers by offering the best quality-tested products while preparing for the next wave of legalized product launches taking place by year's end."
Aurora Cannabis Inc. (ACB) , headquartered in Edmonton, Alberta, Canada with funded capacity in excess of 625,000 kg per annum and sales and operations in 25 countries across five continents, is one of the world's largest and leading cannabis companies. Aurora Cannabis Inc.(ACB) and CTT Pharmaceutical Holdings, Inc., recently announced the successful commercialization of CTT's cannabinoid-infused sublingual wafers. The new cannabis product line, a first of its kind, has been launched by Aurora in the Canadian medical cannabis market under the brand name "Dissolve Strips™". Aurora has an ownership interest in CTT of approximately 9%, with a warrant allowing it to increase its stake to 42.5%, and access to CTT's sublingual wafers drug delivery technology, which is patent protected or patent pending in multiple jurisdictions. "Aurora's Dissolve Strips™ provide unique advantages over other ingestible products due to their ease of administration, discrete nature and accurate dosage, that provides more rapid bioavailability of cannabinoids via sublingual use," said Terry Booth, Chief Executive Officer of Aurora. "This adds yet another innovative offering to our growing portfolio of high quality, medical products that we offer our patient base, and is testament to our industry leading ability to work with technology partners and regulators to bring new form factors to market rapidly."
Harvest Health & Recreation, Inc. (CSE: HARV), headquartered in Tempe, Arizona, is a multi-state cannabis operator (MSO) and vertically-integrated cannabis company. Harvest Health & Recreation, Inc. recently announced the opening of Harvest of Scranton, the third Harvest-affiliated Pennsylvania dispensary in Scranton. Since beginning operations in 2011, Harvest has become known for quality-driven retail experiences, top operational standards and unwavering commitment to serve the communities we enter. "We are thrilled to be expanding our presence in Pennsylvania," said Harvest Chief Executive Officer Steve White. "As our third Harvest-affiliated location in the state, the Scranton dispensary will bring our leading high-quality and trusted experiences to more Pennsylvanians."
Planet 13 Holdings Inc. (CSE: PLTH) is a vertically integrated cannabis company based in Nevada, with award-winning cultivation, production and dispensary operations in Las Vegas. Planet 13 Holdings Inc. recently announced that it had launched a new beverage brand, Elysium, a refreshing THC-infused line of low-calorie flavored sparkling water. "Elysium marks our first step into the exciting THC beverage space. We've created and perfected a sparkling water beverage based on both customer demand and market trends. This low-calorie refreshing drink with zero added sugar was designed to be a fast-acting alternative without the guilt, the perfect micro-dosing beverage," said Bob Groesbeck Co-Chief Executive Officer of Planet 13. "Our expanded production facility will enable us to increase production of our top selling TRENDI line and begin production of Elysium and our highly anticipated edibles lines Dreamland Chocolates and HaHa Gummies. Customers will be able to watch these brands being manufactured behind glass. Increased sales of inhouse brands will drive margin expansion and ultimately shareholder value."
Subscribe Now! Watch us report LIVE https://www.youtube.com/FinancialBuzzMedia
Follow us on Twitter for real time Financial News Updates: https://twitter.com/financialbuzz
Followtalk to us on Instagram: https://www.instagram.com/financialbuzz
Facebook Like Us to receive live feeds: https://www.facebook.com/Financialbuzz/
About FinancialBuzz.com
FinancialBuzz.com, a leading financial news informational web portal designed to provide the latest trends in Market News, Investing News, Personal Finance, Politics, Entertainment, in-depth broadcasts on Stock News, Market Analysis and Company Interviews. A pioneer in the financially driven digital space, video production and integration of social media, FinancialBuzz.com creates 100% unique original content. FinancialBuzz.com also provides financial news PR dissemination, branding, marketing and advertising for third parties for corporate news and original content through our unique media platform that includes Newswire Delivery, Digital Advertising, Social Media Relations, Video Production, Broadcasting, and Financial Publications.
Please Note: FinancialBuzz.com is not a financial advisory or advisor, investment advisor or broker-dealer and do not undertake any activities that would require such registration. The information provided on http://www.FinancialBuzz.com (the 'Site') is either original financial news or paid advertisements provided [exclusively] by our affiliates (sponsored content), FinancialBuzz.com, a financial news media and marketing firm enters into media buys or service agreements with the companies which are the subject to the articles posted on the Site or other editorials for advertising such companies. We are not an independent news media provider and therefore do not represent or warrant that the information posted on the Site is accurate, unbiased or complete. FinancialBuzz.com receives fees for producing and presenting high quality and sophisticated content on FinancialBuzz.com along with other financial news PR media services. FinancialBuzz.com does not offer any personal opinions, recommendations or bias commentary as we purely incorporate public market information along with financial and corporate news. FinancialBuzz.com only aggregates or regurgitates financial or corporate news through our unique financial newswire and media platform. For pasha brands ltd. financial and corporate news dissemination, FinancialBuzz.com has been compensated five thousand dollars by the company. Our fees may be either a flat cash sum or negotiated number of securities of the companies featured on this editorial or site, or a combination thereof. The securities are commonly paid in segments, of which a portion is received upon engagement and the balance is paid on or near the conclusion of the engagement. FinancialBuzz.com will always disclose any compensation in securities or cash payments for financial news PR advertising. FinancialBuzz.com does not undertake to update any of the information on the editorial or Site or continue to post information about any companies the information contained herein is not intended to be used as the basis for investment decisions and should not be considered as investment advice or a recommendation. The information contained herein is not an offer or solicitation to buy, hold or sell any security. FinancialBuzz.com, members and affiliates are not responsible for any gains or losses that result from the opinions expressed on this editorial or Site, company profiles, quotations or in other materials or presentations that it publishes electronically or in print. Investors accept full responsibility for any and all of their investment decisions based on their own independent research and evaluation of their own investment goals, risk tolerance, and financial condition. FinancialBuzz.com. By accessing this editorial and website and any pages thereof, you agree to be bound by the Terms of Use and Privacy Policy, as may be amended from time to time. None of the content issued by FinancialBuzz.com constitutes a recommendation for any investor to purchase, hold or sell any particular security, pursue a particular investment strategy or that any security is suitable for any investor. This publication is provided by FinancialBuzz.com. Each investor is solely responsible for determining whether a particular security or investment strategy is suitable based on their objectives, other securities holdings, financial situation needs, and tax status. You agree to consult with your investment advisor, tax and legal consultant before making any investment decisions. We make no representations as to the completeness, accuracy or timeless of the material provided. All materials are subject to change without notice. Information is obtained from sources believed to be reliable, but its accuracy and completeness are not guaranteed. For our full disclaimer, disclosure and Terms of Use, please visit: http://www.financialbuzz.com.
For further information:
Media Contact:
info@financialbuzz.com
+1-877-601-1879
Url: www.FinancialBuzz.com
Cision View original content:http://www.prnewswire.com/news-releases/officials-promote-the-legal-cannabis-industry-as-health-concerns-abate-300947831.html
SOURCE FinancialBuzz.com
HD, I am just as impatient as you. But the reality is just plain and simple.
We need public information with the improved status of the execution of NGW business plan. A management letter to share holders, extra ordinary expanded sales clients, and or update to the prior management annual sales goals of $30MM once the harvest begin.
Yes, end of November will bring the SEC filing. But can not expect much sales with this report since the harvest just started and they needed drying and curing time of a couple/few weeks before the product could be shipped.
This is more than likely a 2020 story at this point, unless some new business development occurs.
IMHO
Small amount of shares trading here.. Just waiting for real business development news.
That would send the shares into a better trading range.
Next stop $.15 then $.20 and so on and so forth.
Just way too early for this company to recover from the short sellers and very poor weed sector market performance.
And we need a management letter to share holders business update.
Really nice move up at the end of trading day.
Ok, let the games begin..!!!!!
My thoughts exactly. That is why I have been buying shares at these much discounted level.
Waiting for the next upcoming quarterly report due the mid to the end of November. Hopefully management can share some more details.
But the real quart6erly revenue will have to wait for the forth quarter and year end numbers due by the end of the first quarter of 2020.
We will be rewarded, but it will take a few quarters to show and tell what is really happening with NGW,
IMHO!!
Thnks Buhlz I!!
NGW third harvest news release 10/11/19
Today we are 14 days since the last harvest.
Should be news anytime, right??
How about an update NGW!!!!
New on Twitter
Adam22 promotion event Saturday 10/26/19 in San Diego
https://pbs.twimg.com/media/EHrghHGVAAAWQsE.jpg
Should bring much more attention to NGW!!!
Correct either did I. But if your drill within the twitter link you will see the details relating to this.
Likely that they just have not updated their website.
No way!!
We will see $.50 first and $.05 never. IMO
Looks like we are hitting the retail shelves!!!!
March and Ash San Diego
SD Canabis
from twitter
https://pbs.twimg.com/media/EHgPM_VUUAAeIKp.jpg:large
Weed sector under still greatly under downgrade pressure, while we all wait for sales and product news on NGW.
Not much to do here except to wait for the next quarterly at the middle to end of November.
And or add to at these discounted price point levels if your position is not invested to you comfort level.
GLTA
Lets try this link!!
As I said Wow, Wow and more Wow!!
They need a ladder to harvest!!
https://pbs.twimg.com/media/EHBIikvUYAAE6Aa.jpg
Sorry could not post link...Just sign in to twitter and enter Next Green Wave in the search.
If you follow NGW should open automatically
NGW new on twitter. Wow, Wow and more Wow!!
Sorry could not paste the photo, but it is very impressive!!!
Reaching higher... craft is where it is at! From gene to trim, you know where it has been #cannabis #California #quality $ngw $nxgwf #growing
Yes, long term we should be making a lot of money here. But guys, please remember this a penny stock. Without any broker coverage.
We have a lot of stock share price work to go thru given the recent sell off.
For me I see price next resistance at $.175 and then $.185.
Open a day chart to see in detail what I am making reference to.
Oh, yes not to mention the year end tax loss selling.
However that being said, any good news statement about sales or an extra ordinary distribution deal that NGW would announce would easily move us pass these resistance share price point and a much higher into the $.25 price range. And possibly more.
IHMO.
Guys, for me it just does not matter for a few cents what your entry level. Since NGW is trading at a much discounted share price to the market cap value of the company.
Market cap value = total shares outstanding x share price
As of June 2019 NGW public investor information deck on their web site there was approx. 156,000,000 shares outstanding.
So 156,000,000 times $.1535 = $23,946,000.
Management forecast sales $$ for 12 months from Aug. 2019 recently stated at $30,000,000
So at these prices we are trading at 24/30 = 0.80 times sales.
When NGW issues any sales updates of the next few quarter. And when NGW shows the sales at or near the recently stated yearly sales goal, the market will react with a much, much higher sales price.
Share price to sales for market cap in this sector runs several times these current NGW numbers.
For me we should easily see market cap of 5 times sales.
Taking us easily to a share price of $.75 within the next 12 months.
The above is when the few cents of entry price really just does not matter, IMO,
Some more education while we enjoy the upward price move
Oct. 9 twitter NGW twitter about trichome heads looking ripe.
Looking good to me!!!!
https://www.leafly.com/news/cannabis-101/what-are-trichomes-on-cannabis
NGW is bid up while the total cannabis sector is trading down with down grades.
Go figure??
All Content and Data provided by Third-Parties — Terms of Use
Canopy Growth, Hexo downgraded by Seaport; analysts recommend switch to US cannabis sector from Canadian
MARKETWATCH 8:37 AM ET 10/14/2019
Symbol Last Price Change
HEXO 2.3up -0.23 (-9.09%)
CGC 18.25down -1.18 (-6.07%)
ACB 3.41down -0.27 (-7.34%)
TLRY 20.4947up -0.4653 (-2.22%)
APHA 4.31down -0.4 (-8.49%)
TGOWF 0.3up 0 (0%)
MJ 18.1301down -0.5199 (-2.79%)
QUOTES AS OF 10:15:37 AM ET 10/14/2019
Seaport Global downgraded Canadian cannabis companies Hexo Corp.(HEXO) and Canopy Growth Corp.(CGC) to neutral from buy on Monday, and reiterated neutral ratings on Aurora Cannabis Inc.(ACB) and Tilray Inc.(TLRY) , leaving Aphria Inc.(APHA) as the only buy-rated Canadian cannabis company in its coverage. "We see a headwind for the Canadian cannabis market, ahead, based on sizable industry supply that will aim to funnel into a limited retail store set," analysts Brett M. Hundley and Luke Perda wrote in a note to clients. "We expect pricing and margins to drop considerably." The analysts said their model, rating and price target for Green Organic Dutchman(TGOWF) are under review, pending news on its efforts to get fresh financing. In the U.S. multi-state operator space, the analysts "see a completely different set of circumstances in place, and we would broadly recommend that investors rotate away from Canada and towards the US," they wrote. "We do not think that recent vape headlines will materially cut into forward MSO financials, and we see a number of opportunities for public MSOs on the horizon." Canopy shares were down 0.8% in premarket trade, while Hexo(HEXO) was down 4.7%. The ETFMG Alternative Harvest ETF(MJ) was up 1.1%, but has fallen 25% in 2019, while the S&P 500 has gained 18%.
-Ciara Linnane; 415-439-6400; AskNewswires@dowjones.com
(END) Dow Jones Newswires
10-14-190837ET
Copyright (c) 2019 Dow Jones & Company,
Since we made the investment in NGW, time for some education about the process of extraction
https://keytocannabis.com/blogs/cannabis/the-solventless-hash-rating-system-how-to-determine-quality
NGW closed at $.195 CAD
US dollar to CAD 1.32 exchange
$.195 divided by 1.32 equals $ .1477
So NXGWF should be trading higher real soon.
GLTA
Thks Bulhz!!! I agree with your estimates.
However it does seem that are running a bit short of the $30 MM annual, as of now.
Clone plantlets $$, and THC concentrates $$ are not yet in the revenue stream.
We just need management to step up here. Although it just might be a bit early in their game.
Looking for some up lift for 3rd quarter release of numbers. And management comment about their current and future business plan.
Thks Bulhz!!! I agree with your estimates.
However it does seem that are running a bit short of the $30 MM annual, as of now.
Clone plantlets $$, and THC concentrates $$ are not yet in the revenue stream.
We just need management to step up here. Although it just might be a bit early in their game.
Looking for some up lift for 3rd quarter release of numbers. And management comment about their current and future business plan.
OK, by the end of this month NGW should have 3 production harvest under it belt. (first harvest being a test, so we just give them a pass.)
NGW management needs to confirm or adjust (up or down) their prior annual revenue projection of $30,000,000. That being said for the annual revenue once the continual harvests begin.
Time for management to step up here by month end. Or at worst care include this detail business $$ forecast into their 3rd quarter SEC filings news release.
Good sign today if it stays this way.
NGW trading up.
Sector is trading down.
Check out stock symbols, for example
MJ
ACB
trading down today
Simply stated if you own the warrant at a certain exercise price you have the right to purchase common shares at that exercise price by the date authorized to you.
In this case you can purchase NNGWF at $.48 until May 2021.
After that date the warrants expire worthless.
I hope this helps you.